Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...

A decision about how to spend settlement funds in Carter County, Kentucky, which was hit hard by the opioid epidemic, offers ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

Young adults who struggle with attention difficulties may be more prone to becoming addicted to social media, and a new study ...

Residents testified they were concerned about drug rehab patients wandering into Century Village late at night and breaking ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Although the United States government partly funded buprenorphine’s development as a treatment for opioid addiction, France was one of the first countries to most fully exploit its potential.